Regulation of the innate immune response by fibronectin: Synergism between the III-1 and EDA domains

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Kelsh, Rhiannon ^a   You, Ran ^a   Horzempa, Carol ^a   Zheng, Mingzhe ^a   McKeown Longo, Paula J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; ISOPROTEIN; MAP-KINASE-ACTIVATED KINASE 2; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TLR4 PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; CXCL1 GENE; CXCL2 GENE; CXCL3 GENE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FIBROBLAST; FNEDA DOMAIN; FNIII 1 DOMAIN; GENE EXPRESSION; GENE EXPRESSION PROFILING; IL 8 GENE; IMMUNOREGULATION; INNATE IMMUNITY; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN UNFOLDING; RNA STABILITY; SIGNAL TRANSDUCTION; TNF ALPHA GENE; BINDING SITE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DERMIS; DRUG EFFECTS; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOBLOTTING; METABOLISM; PROTEIN TERTIARY STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ALTERNATIVE SPLICING; BINDING SITES; CELL LINE, TUMOR; CELLS, CULTURED; CYTOKINES; DERMIS; DRUG SYNERGISM; FIBROBLASTS; FIBRONECTINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNOBLOTTING; INFLAMMATION MEDIATORS; INTERLEUKIN-8; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84904667031     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102974     Document Type: Article

References (75)

1. Bradshaw MJ, Smith ML (2013) Multiscale relationships between fibronectin structure and functional properties. Acta Biomater. Available: http://dx.doi.org/10.1016/j.actbio.2013.08.027.
2. Peleg O, Savin T, Kolmakov GV, Salib IG, Balazs AC, et al. (2012) Fibers with integrated mechanochemical switches: minimalistic design principles derived from fibronectin. Biophys J 103: 1909-1918.
3. Muro AF, Iaconcig A, Baralle FE (1998) Regulation of the fibronectin EDA exon alternative splicing. Cooperative role of the exonic enhancer element and the 59 splicing site. FEBS Lett 437: 137-141. (Pubitemid 28498256)
4. Watanabe K, Takahashi H, Habu Y, Kamiya-Kubushiro N, Kamiya S, et al. (2000) Interaction with heparin and matrix metalloproteinase 2 cleavage expose a cryptic anti-adhesive site of fibronectin. Biochemistry 39: 7138-7144. (Pubitemid 30413102)
5. Schedin P, Strange R, Mitrenga T, Wolfe P, Kaeck M (2000) Fibronectin fragments induce MMP activity in mouse mammary epithelial cells: evidence for a role in mammary tissue remodeling. J Cell Sci 113: 795-806. (Pubitemid 30168648)
6. Sofat N (2009) Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int J Exp Pathol 90: 463-479.
7. Smith ML, Gourdon D, Little WC, Kubow KE, Eguiluz RA, et al. (2007) Force-induced unfolding of fibronectin in the extracellular matrix of living cells. PLoS Biol 5 (e268): 2243-2254. (Pubitemid 350035426)
8. Hocking DC, Smith RK, McKeown-Longo PJ (1996) A novel role for the integrin-binding III-10 module in fibronectin matrix assembly. J Cell Biol 133: 431-444. (Pubitemid 26132539)
9. Zhong C, Chrzanowska-Wodnicka M, Brown J, Shaub A, Belkin AM, et al. (1998) Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J Cell Biol 141: 539-551. (Pubitemid 28237100)
10. Gee EP, Yuksel D, Stultz CM, Ingber DE (2013) SLLISWD sequence in the 10FNIII domain initiates fibronectin fibrillogenesis. J Biol Chem 288: 21329-21340.
11. Vakonakis I, Staunton D, Ellis IR, Sarkies P, Flanagan A, et al. (2009) Motogenic sites in human fibronectin are masked by long range interactions. J Biol Chem 284: 15668-15675.
12. Krammer A, Craig D, Thomas WE, Schulten K, Vogel V (2002) A structural model for force regulated integrin binding to fibronectin's RGF-synergy site. Matrix Biol 21: 139-147. (Pubitemid 34145240)
13. Mao Y, Schwarzbauer JE (2005) Stimulatory effects of a three-dimensional microenvironment on cell-mediated fibronectin fibrillogenesis. J Cell Sci 118: 4427-4436. (Pubitemid 41556341)
14. Shinde AV, Bystroff C, Wang C, Vogelezang MG, Vincent PA, et al. (2008) Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin a9b1-dependent cellular activities. J Biol Chem 283: 2858-2870.
15. Miura S, Kamiya S, Saito Y, Wada S, Hayashi R, et al. (2007) Antiadhesive sites present in the fibronectin type III-like repeats of human plasma fibronectin. Biol Pharm Bull 30: 891-897. (Pubitemid 46708631)
16. Mitsi M, Forsten-Williams K, Gopalakrishnan M, Nugent MA (2008) A catalytic role of heparin within the extracellular matrix. J Biol Chem 283: 34796-34807.
17. Chabria M, Hertig S, Smith ML, Vogel V (2010) Stretching fibronectin fibres disrupts binding of bacterial adhesins by physicially destroying an epitope. Nature Communications 1: 135.
18. O'Neill LA, Bryant CE, Doyle SL (2009) Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev 61: 177-197.
19. Terhorst D, Kalali BN, Ollert M, Ring J, Mempel M (2010) The role of toll-like receptors in host defenses and their relevance to dermatologic diseases. Am J Clin Dermatol 11: 1-10.
20. Gondokaryono SP, Ushio H, Niyonsaba F, Hara M, Takenaka H, et al. (2007) The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukocyte Biol 82: 657-665. (Pubitemid 47367158)
21. McFadden JP, Basketter DA, Dearman RJ, Kimber IR (2011) Extra domain A-positive fibronectin-positive feedback loops and their association with cutaneous inflammatory disease. Clin Dermatol 29: 257-265.
22. Zheng M, Jones DM, Horzempa C, Prasad A, McKeown-Longo PM (2011) The first type III domain of fibronectin is associated with the expression of cytokines within the lung tumor microenvironment. J Cancer 2: 478-483.
23. You R, Zheng M, McKeown-Longo PJ (2010) The first type III repeat in fibronectin activates an inflammatory pathway in dermal fibroblasts. J Biol Chem 285: 36255-36259.
24. Gao M, Craig D, Lequin O, Campbell ID, Vogel V, et al. (2003) Structure and functional significance of mechanically unfolded fibronectin type III1 intermediates. Proc Natl Acad Sci 100: 14784-14789. (Pubitemid 37517968)
25. Briknarova K, Akerman ME, Hoyt DW, Ruoslahti E, Ely KR (2003) Anastellin, an FN3 fragment with fibronectin polymerization activity, resembles amyloid fibril precursors. J Mol Biol 332: 205-215. (Pubitemid 36999742)
26. Doucet A, Overall CM (2011) Broad coverage identification of multiple proteolytic cleavage site sequences in complex high molecular weight proteins using quantitative proteomics as a complement to edman sequencing. Mol Cell Proteomics 10: M110.003533.
27. Klein RM, Zheng M, Ambesi A, van de Water L, McKeown-Longo PJ (2003) Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin. J Cell Sci 116: 4663-4674. (Pubitemid 37461620)
28. Chandler EM, Saunders MP, Yoon CJ, Gourdon D, Fishbach C (2011) Adipose progenitor cells increase fibronectin matrix strain and unfolding in breast tumors. Phys Biol 8: 015008-doi:10.1088/1478-3975/8/1/015008.
29. You R, Klein RM, Zheng M, McKeown-Longo PJ (2009) Regulation of p38 MAP kinase by anastellin is independent of anastellin's effect on matrix fibronectin. Matrix Biol 28: 101-109.
30. Ronkina N, Kotlyarov A, Gaestel M (2008) MK2 and MK3-a pair of isoenzymes. Front Biosci 13: 5511-5521.
31. Busby TF, Argraves WS, Brew SA, Pechik I, Gilliland GL, et al. (1995) Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle. J Biol Chem 270: 18558-18562.
32. Gee EP, Ingber DE, Stultz CM (2008) Fibronectin unfolding revisited: modeling cell traction-mediated unfolding of the tenth type-III repeat. PLoS ONE 3: e2373.
33. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, et al. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 18: 4969-4980. (Pubitemid 29443799)
34. Udalova IA, Ruhmann M, Thomson SJ, Midwood KS (2011) Expression and immune function of tenascin-C. Crit Rev Immunol 32: 115-145.
35. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, et al. (2009) Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nature Med 15: 774-780.
36. Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM (2011) Dynamic reciprocity in the wound microenvironment. Wound Repair Regen 19: 134-148.
37. Erridge C (2010) Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukocyte Biol 87: 989-999.
38. Schumacher C, Clark-Lewis I, Baggiolini M, Moser B (1992) High- and low-affinity binding of GROa and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci USA 89: 10542-10546.
39. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, et al. (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276: 10229-10233.
40. Knapinska AM, Irizarry-Barreto P, Adusumalli S, Andorulakis I, Brewer G (2005) Molecular mechanisms regulating mRNA stability: Physiological and pathological significance. Current Genomics 6: 471-486. (Pubitemid 41671666)
41. Akira S (2003) Mammalian Toll-like receptors. Curr Opin Immunol 15: 5-11.
42. Bowie A, O'Neill LAJ (2000) The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leuk Biol 67: 508-514.
43. Frevel MAE, Bakheet T, Silva AM, Hissong JG, Khabar KSA, et al. (2003) p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol Cell Biol 23: 425-436. (Pubitemid 36050538)
44. Neininger A, Kontoyiannis D, Kotlyarov A, Winzen R, Eckert R, et al. (2002) MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J Biol Chem 277: 3065-3068. (Pubitemid 34953164)
45. An H, Yu Y, Zhang M, Xu H, Qi R, et al. (2002) Involvement of ERK, p38 and NF-kB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 106: 38-45. (Pubitemid 34437875)
46. Bode JG, Ehlting C, Häussinger D (2012) The macrophage response towards LPS and its control through the p38MAPK-STAT3 axis. Cell Signal 24: 1185-1194.
47. Kumar P, Amin MA, Harlow LA, Polverini PJ, Koch AE (2003) Src and phosphatidylinositol 3-kinase mediate soluble E-selectin-induced angiogenesis. Blood 101: 3960-3968. (Pubitemid 36857873)
48. Sweeney SE, Firestein GS (2006) Mitogen activated protein kinase inhibitors: where are we now and where are we going? Ann Rheum Dis 65 (Suppl III): iii83-iii88. (Pubitemid 44629110)
49. Piccinini AM, Midwood KS (2012) Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155. Cell Rep 2: 914-926.
50. Miyake K (2006) Roles for accessory molecules in microbial recognition by Toll-like receptors. J Endotoxin Res 12: 195-204.
51. Park BS, Song DH, Kim HM, Choi BS, Lee H, et al. (2009) The structural basis of lipopolysaccharaide recognition by the TLR4-MD-2 complex. Nature 458: 1191-1195.
52. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, et al. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11: 155-161.
53. Taylor KR, Yamasaki K, Radek KA, DiNardo A, Goodarzi H, et al. (2007) Recognitioin of hyaluronan released in sterile injury involves a unique receptor complex dependent on toll-like receptor 4, CD44, and MD-2. J Biol Chem 282: 18265-18275. (Pubitemid 47100227)
54. Kelsh RM, McKeown-Longo PJ (2013) Topographical changes in extracellular matrix: Activation of TLR4 signaling and solid tumor progression. Trends in Cancer Res 9: 1-13.
55. Schor SL, Schor AM (2001) Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res 3: 373-379. (Pubitemid 34196363)
56. Pan Q, Chathery Y, Wu Y, Rathore N, Tong RK, et al. (2007) Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J Biol Chem 282: 24049-24056. (Pubitemid 47328044)
57. Homandberg GA (1999) Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments. Front Biosci 4: D713-D730.
58. Morla A, Ruoslahti E (1992) A fibronectin self-assembly site involved in fibronectin matrix assembly: reconstruction in a synthetic peptide. J Cell Biol 118: 421-429.
59. Hocking DC, Sottile J, McKeown-Longo PJ (1994) Fibronectin's III-1 module contains a conformation-dependent binding site for the amino-terminal region of fibronectin. J Biol Chem 269: 19183-19187.
60. Hocking DC, Kowalski K (2002) A cryptic fragment from fibronectin's III1 modulate localizes to lipid rafts and stimulates cell growth and contractility. J Cell Biol 158: 175-184.
61. Hocking DC, Titus PA, Sumagin R, Sarelius IH (2008) Extracellular matrix fibronectin mechanically couples skeletal muscle contraction with local vasodilation. Circ Res 102: 372-379. (Pubitemid 351271658)
62. Feaver RE, Gelfand BD, Wang C, Schwartz MA, Blackman BR (2010) Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation. Circ Res 106: 1703-1711.
63. Kendal-Wright CE, Hubbard D, Gowin-Brown JH, Bryant-Greenwoord GD (2010) Stretch and inflammation-induced Pre-B cell colony-enhancing factor (PBEF/Visfatin) and interleukin-8 in amniotic epithelial cells. Placenta 31: 665-674.
64. Bradshaw MJ, Cheung MC, Ehrlich DJ, Smith ML (2012) Using molecular mechanics to predict bulk material properties of fibronectin fibers. PLoS Comput Biol 8: e1002845- doi:10.1371/journal.pcbi1002845. Epub 2012 Dec 27.
65. Deno DC, Saba TM, Lewis EP (1983) Kinetics of endogenously labeled plasma fibronectin: Incorporation into tissues. Am J Physiol 245: R564-R575. (Pubitemid 13023332)
66. Moretti FA, Chauhan AK, Iaconcig A, Porro F, Baralle FE, et al. (2007) A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem 282: 28057-28062. (Pubitemid 47529518)
67. Oh E, Pierschbacher M, Ruoslahti E (1981) Deposition of plasma fibronectin in tissues. Proc Natl Acad Sci 78: 3218-3221.
68. Thompson C, Blumenstock FA, Saba TM, Feustel PJ, Kaplan JE, et al. (1989) Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation. J Clin Invest 84: 1226-1235. (Pubitemid 19247595)
69. Booth AJ, Wood SC, Cornett AM, Dreffs AA, Lu G, et al. (2012) Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis. J Pathol 226: 609-618.
70. Volz KS, Miljan E, Khoo A, Cooke JP (2012) Development of pluriopotent stem cells for vascular therapy. Vascul Pharmacol 56: 288-296.
71. Arslan F, Smeets MB, Riem Vis PW, Karper JC, Quax PH, et al. (2011) Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction. Circ Res 108: 582-592.
72. Khan MM, Gandhi C, Chauhan N, Stevens JW, Motto DG, et al. (2012) Alternatively-spliced extra domain A of fibronectin promotes acute inflammation and brain injury after cerebral ischemia in mice. Stroke 43: 1376-1382.
73. Hirshoren N, Kohan M, Assayag M, Neuman T, Vernea F, et al. (2013) Extra domain-A fibronectin is necessary for the development of nasal remodeling in chronic allergen-induced rhinitis. Ann Allergy Asthma Immunol 110: 322-327.
74. van der Straaten HM, Canninga-van Dijk MR, Verdonck LF, Castigliego D, Borst HP, et al. (2004) Extra-domain-A fibronectin: a new marker of fibrosis in cutaneous graft-versus-host disease. J Invest Dermatol 123: 1057-1062. (Pubitemid 39586826)
75. Mogami H, Kishore AH, Shi H, Keller PW, Akgul Y, et al. (2013) Fetal fibronectin signaling induces matrix metalloproteases and cyclooxygenase-2 (COX-2) in amnion cells and preterm birth in mice. J Biol Chem 288: 1953-1966.